NCT07357207 2026-01-23VIT-BCIzmir Biomedicine and Genome CenterPhase NA Enrolling by invitation80 enrolled
NCT06254066 2024-02-12Adebrelimab Combined With Fluzoparib in HRD-positive HR +/HER2- Advanced Breast CancerZhejiang Cancer HospitalPhase 2 Not yet recruiting40 enrolled